Sort by
Refine Your Search
-
Listed
-
Employer
- Centre for Genomic Regulation
- Computer Vision Center
- Institut de Físiques d'Altes Energies (IFAE)
- Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
- Catalan Institute for Water Research (ICRA)
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron (VHIO)
- ICFO - The Institute of Photonic Sciences
- ICN2
- Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)
- Institut de Recerca Biomèdica de Lleida, Fundació Dr. Pifarré (IRBLleida)
- Institut d’Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI-CERCA)
- Institute of Photonic Sciences
- Nature Careers
- Principe Felipe Research Center
- UNIVERSIDAD POLITECNICA DE MADRID
- Universitat Politècnica de Catalunya (UPC)- BarcelonaTECH
- Universitat de Barcelona
- 8 more »
- « less
-
Field
-
Post-doctoral researcher - Target Identification and Validation for Personalized Medicine. REF. 25-201_R_FF IDIBELL is looking for a Postdoctoral Researcher in Target Identification and Validation
-
parameter estimation Knowledge of advanced Bayesian methods and samplers, machine learning approaches to signal processing; additionally other methods such as simulation-based inference Good computing skills
-
cnidarians. The successful candidate will combine targeted perturbation experiments with high-throughput single-cell molecular profiling to validate cell-lineage gene regulatory networks. We welcome
-
) acquire a pathological fibrotic and immunosuppressive state that promotes tumor progression. Using a set of preclinical models, the project aims to identify novel therapeutic targets and biomarkers based
-
and consistent with our pay scales · Target start date: February 2026 We provide a highly stimulating environment with state-of-the-art infrastructures, and unique professional career development
-
Transplantation Research Group and related to the Duacept PERIS grant. Duacept introduces the development of novel immunomodulatory molecule targeting specific Costimulation receptors aiming at inhibiting and
-
experimental and in silico approaches to elucidate the biological basis of breast cancer initiation and increased cancer risk, with the ultimate goal of identifying and developing targeted preventive and
-
gross salary: Salary is commensurate with qualifications and consistent with our pay scales. · Target start date: February 1, 2026. We provide a highly stimulating environment with state
-
with our pay scales Target start date: As soon as possible We provide a highly stimulating environment with state-of-the-art infrastructures, and unique professional career development opportunities
-
20 months) Estimated annual gross salary: Salary is commensurate with qualifications and consistent with our pay scales Target start date: As soon as possible We provide a highly stimulating